Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.
Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.
Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.
“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.
No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.
The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.
Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.
Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.
Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.
Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.
Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.
Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.
Credit: UNIGME
With interventions targeted towards improving maternal and child health along with quality and accessible health infrastructure, India has played a crucial role in the decline of global child mortality, especially in South Asia, according to a UN report today.
The UN Inter-agency Group for Child Mortality Estimation (UNIGME) Report 2025 highlighted that the country's sustained efforts in the last two decades in child health have led to significant outcomes in South Asia. They include:
"India emerges as a leading global exemplar in the UN IGME 2025 report for accelerating child mortality reduction," JP Nadda, Union Health Minister, shared in a post on X.
"India’s focussed comprehensive approach on neonatal care has paved the way for eliminating preventable child deaths and securing healthy future for our children," he added.
Also read: 4.9 Million Children Died Before Age Five Worldwide In 2024: UN Report
In India, the UNIGME report showed that:
The report lauded India’s "continuum-of-care strategy" that has integrated sustained strengthening of a vibrant health system with commensurate expansion of its health infrastructure.
It also hailed demand-driven programmatic interventions in reducing preventable maternal and newborn mortality. These include:
Further, it noted that India’s commitment to improving newborn and child survival has also been reflected in continuous quality improvement initiatives such as the recently released guidelines on Facility-Based Newborn Care (FBNC) and
digital innovations such as Tele-SNCU (HUB & SPOKE model).
These efforts are complemented by hybrid skill-based learning modules on the safe and rational use of oxygen (including CPAP) and by the empowerment of mothers and caregivers to provide nurturing care to small and sick newborns.
"India is among the first few countries to set targets and release operational guidelines on Stillbirth Surveillance and response," the report said.
The UN noted that India’s experience shows that "sustained leadership, strategic investments, and strong collaboration with committed stakeholders have enabled a robust, scalable, and effective implementation framework targeted towards the achievement of the SDGs".
Credit: Sansad TV/X
Finance Minister Nirmala Sitharaman has announced in the Parliament that India is planning to launch universal health coverage for all by 2033.
Addressing the Rajya Sabha, the Finance Minister stated that health insurance has become a priority area for the government, and informed that the sector has made significant progress, covering 58 crore lives in 2024–25, news agency PTI reported.
“Health insurance is a priority for this government. In fact, we are hoping that by 2033 we will have insurance cover for all,” Sitharaman said.
The FM added that the total health premium collections in the country reached Rs 1,17,505 crore in 2024–25. The health premiums under
“Health insurance is now a clear priority with GST exemption on individual premiums, expansion of coverage, and strong regulatory push driving the momentum,” she said.
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), the world’s largest publicly funded health insurance scheme, launched in 2018, provides health cover of Rs 5 lakh per family per year. It provides secondary and tertiary care hospitalization to about 12 crore families, representing the bottom 40 per cent of the population.
The scheme was further expanded to cover 6 crore senior citizens of age 70 years and above, belonging to 4.5 crore families, irrespective of their socio-economic status.
Union Minister of State for Health and Family Welfare, Prataprao Jadhav, stated in a written reply in the Rajya Sabha that
till February 28:
Further, the latest national master of Health Benefit Package provides cashless healthcare services for 1,961 procedures across 27 medical specialties.
“A total of 11.69 crore hospital admissions amounting to Rs. 1.73 lakh crore have been authorized under the scheme,” Jadhav said.
He added that more than 86 crore Ayushman Bharat Health Accounts (ABHA) have been created, and more than 90 Crore health records have been linked to patients’ ABHA.
In addition, Ayushman Bharat Digital Mission (ABDM) was launched in India in September 2021 to support the development of an integrated and citizen-centric national digital health ecosystem.
Till March 11, the progress made under ABDM includes:
Credit: iStock
India’s Human Papillomavirus (HPV) vaccination drive that began a fortnight ago has already vaccinated nearly 3 lakh girls aged 14 years, according to the Union Health Ministry.
The nationwide free HPV vaccination campaign for girls aged 14 years was launched by Prime Minister Narendra Modi from Rajasthan's Ajmer on February 28.
“Within just a fortnight of its launch, nearly 3 lakh girls aged 14 years have already been vaccinated—marking an encouraging start to this critical public health initiative,” the health ministry said.
"The enthusiastic participation seen so far reflects growing awareness among parents, schools, and communities about the importance of early protection," it added.
Further, the Ministry noted that several states, including Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Gujarat, Odisha, and Mizoram, have seen a significant uptake in the nationwide HPV vaccination campaign.
The initiative marked a decisive step towards eliminating cervical cancer through timely HPV vaccination.
Cervical cancer remains the second most common cancer among women in India. Nearly 80,000 new cases and over 42,000 deaths are reported annually in the country.
The Ministry said that despite examinations currently underway in many regions, the response to the campaign has remained strong, and the momentum is expected to accelerate significantly in the coming days.
“We are leaving no stone unturned to ensure that the daughters of the country are healthy and prosperous. The objective of this initiative is the prevention of cervical cancer," the Prime Minister, earlier wrote in a post on social media platform X.
The government has urged parents and guardians to support and encourage eligible girls to get vaccinated at the earliest.
HPV vaccination is voluntary, and parental consent is mandatory before administration of the vaccine.
The single-dose Gardasil-4 vaccine is administered free of cost at government health facilities across all areas, including rural and underserved areas, and will be available even after the campaign ends.
The vaccine used is non-live and does not cause HPV infection. It is supported by more than 500 million doses administered globally since its introduction in 2006.
The vaccine is most effective when it is administered before exposure to HPV and before becoming sexually active. Young women aged 9 to 14 years show vaccine effectiveness of 74 to 93 per cent and this decreases with age.
To avail the free HPV vaccine, visit any government health facilities including
© 2024 Bennett, Coleman & Company Limited